Solaris Pharma Corporation is a leading specialty pharmaceutical company committed to identifying, developing, and marketing complex high-quality, generic, and specialty pharmaceutical products.

Solaris Pharma Corporation

Solaris Pharma Corporation was founded in 2014 with the vision of improving the patients’ quality of life through development of niche pharmaceutical products. Located in Bridgewater, New Jersey, Solaris Pharma Corporation has a fully equipped Research & Development facility with expertise in the development of generic and specialty products. Solaris Pharma Corporation is uniquely poised to develop specialty dermatology products that have a relatively high barrier to entry due to manufacturing complexities and high-end clinical patient study demands.

With a thorough knowledge of the development life cycle and well-trained, committed scientific personnel, Solaris Pharma Corporation has streamlined processes that are efficient in reducing development costs and shortening timelines, without compromise in quality.

Solaris Pharma Corporation is currently engaged in the development of several generic dermatology products and is committed to establish itself as a pacesetter in dermatology pharmaceuticals.

Solaris Pharma's 2023 Annual Holiday Celebration!

Solaris Pharma would like to wish everyone and their families a Blessed, Safe and Happy Thanksgiving! 

Solaris is currently in the development of several generic dermatology products & is committed to establish itself as a pacesetter in dermatology pharmaceuticals. We are looking for a F/T R&D Scientist with Tech Transfer experience. If you're interested or know someone, contact me at 908-800-0323 or rmarrero@solaris-pharma.com

How are you today? Tell us what you want to hear from us.

If you want to stay up-to-date with us, follow our Page.

Metric
Company Name	Solaris Pharma Corporation
Symbol
MSH ID	COM:SOLARIS-PHARMA
Market	PRIVATE
Sector	8
Industry	Healthcare & Health Services
Country	US
Stage
Employee Count	30
Website	solaris-pharma.com
LinkedIn	solaris-pharma-corporation
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	1.36K
Web Traffic Growth	0.16
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score	10.25
28-Day Growth Score	16.27
90-Day Growth Score	25.24
365-Day Growth Score	19.53

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:SOLARIS-PHARMA

Solaris Pharma Corporation

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue